Log in


We are excited to announce the recipients of the Rafaelsen Young Investigators Award 2026:

  • Benson Ku, USA
  • Martin Osugo, UK
  • Anjali Sankar, Denmark

Due to a very high number of entries of exceptional quality, the following applicants have been awarded a President's Recognition for Young Investigators diploma:

  • Shokouh Arjmand, Denmark
  • Dibyadeep Datta, USA
  • Vivian Marcela Garzon Rubiano, Colombia
  • Martha Lopez-Canul, Canada
  • Chiara Montemitro, Italy
  • Devon Stoliker, Australia
  • Biju Viswanath, India

Congratulations to all awardees!

All Details About Awards


We are pleased to share a new Genomic Press Interview with Dr. Gabriella Gobbi, CINP President Elect, Professor of Psychiatry at McGill University, and Canada Research Chair in Therapeutics for Mental Health.

From pioneering research on adolescent cannabis exposure and depression, to advancing novel melatonin receptor therapeutics, and early work on the neurobiology of psychedelics - Dr. Gobbi’s career exemplifies truly translational science.

As the first woman elected CINP President in its 70-year history, she reflects on her journey from Italy to Canada, the clinical insights that shaped her research, and her vision for a neuropsychopharmacology that remains deeply connected to patient care.

Read the full interview


CINP is pleased to introduce the Daniela Parolaro Prize, established in collaboration with the Zardi–Gori Foundation for Addiction Research.

Created in memory of Professor Daniela Parolaro, this award honors her outstanding contributions to the neuroscience of addiction and her dedication to advancing experimental research in substance use disorders.

The prize recognizes researchers who are making impactful contributions to the field of addiction science and aims to support the next generation of leaders in neuropsychopharmacology.

Nominations are now open - discover more about the prize, eligibility criteria, and how to apply.

Deadline for application: 
April 1, 2026.

Find Out More


The CINP Early Careers Committee is pleased to announce the CINP Research Fellowships 2026, aimed at supporting early-career researchers and clinicians working in the field of neuropsychopharmacology.

This year’s theme - Neuropsychopharmacology of Addiction and Substance Use - focuses on the neuropsychopharmacology of addiction and substance use, exploring cutting-edge research and clinical perspectives that advance our understanding of substance use disorders. 

The programme includes online teaching modules with top researchers in their fields as well as an in-person colloquium that will take place immediately before the CINP 2026 Congress in Glasgow on 26th June 2026.

Deadline for application: 
March 24, 2026.

Learn More & Apply


We are delighted to announce the recipients of the CINP Student Encouragement Award 2026:

  • Giuseppe De Simone, Italy
  • Carina Donegan, New Zealand
  • Wenjie Hou, China
  • Federica Iannotta, Italy
  • Talah Khoury, Slovakia
  • Takatoshi Sakata, Japan
  • Asilay Seker, United Kingdom
  • Nicoleta Sirbu, United Kingdom
  • Angel Yonehara, Australia
  • Maia Zilberman, Canada

The CINP Fellowship and Awards Committee decided to also award several President's Special Commendation Diplomas to appreciate the high quality of the received applications.

View All Details

Congratulations to all awardees!



We are excited to announce the preparation of an International Course in Psychopharmacology, designed for residents in psychiatry and neurology, psychiatrists, neurologists, and general practitioners, and everybody who wishes to deepen their understanding of the mechanisms and clinical applications of psychopharmacological treatments.

Through this program, CINP seeks to foster global learning, professional development, and the dissemination of evidence-based neuropsychopharmacology.

The course will be online, CME-accredited, with sessions held every Thursday for several consecutive weeks. The first edition of the course is planned for the second half of 2026.

More information coming soon!

Register Your Interest



GLOBAL
Guidelines

Read the various treatment guidelines  written by CINP Members and endorsed by CINP.


International Journal of Neuropsychopharmacology

Impact Factor: 3.7